Neurogenomics Industry to Achieve $2.60 Billion Growth by 2029

Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.

How Will the Neurogenomics Market Grow by 2025 in Terms of Size and Growth?
The scale of the neurogenomics market has quickly expanded in the past few years. Its growth is projected to rise from $1.31 billion in 2024 to $1.50 billion in 2025, with a compound annual growth rate (CAGR) of 15.0%. This rise in the historic period is the result of increased demand for genetic testing in the area of neurological disorders, expanded research into the connection between the brain, behavior, and genome, a growing incidence of neurodegenerative diseases, more financial support for neuroscience research, and an increase in the number of biobanks and genomic databases.

What Are the Estimated Growth Rates for the Neurogenomics Industry Through 2029?
In the coming years, rapid expansion is anticipated in the neurogenomics market. With a compound annual growth rate (CAGR) of 14.7%, it is predicted to surge to $2.60 billion by 2029. This projected growth in the forecast period can be ascribed to the rising interest in customized mental health treatments, an increase in direct-to-consumer neurogenetic testing usage, a growing preference for multi-omics approaches, enhanced precision neurology initiatives, and the rising endorsement of targeted therapies. Some key trends during the forecast period include development of artificial intelligence-led genomic analytics, the creation of non-invasive diagnostic platforms, the integration of multi-omics approaches, the incorporation of genomics into precision neurology, and innovative strides in neurodegenerative disease modelling.

Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/neurogenomics-global-market-report

What Are the Strategic Drivers Boosting Neurogenomics Market Performance?
The growth of the neurogenomics market is anticipated to be fueled by the increasing occurrence of neurological disorders. Neurological disorders are medical conditions that impact the brain, spinal cord, or nerves, and can lead to symptoms like muscle weakness, seizures, pain, and cognitive difficulties. This rising prevalence is largely attributed to lifestyle elements such as poor nutrition, sedentary behavior, chronic stress, and increased exposure to environmental toxins. Neurogenomics offers an in-depth comprehension of the genetic underpinnings of brain functionality and dysfunction, paving the way for the identification of causes, improved diagnostics, and personalized treatments for these disorders. For example, as per the Alzheimer's Association, a voluntary health organization in the U.S., around 6.7 million American citizens, aged 65 or older, were diagnosed with Alzheimer's dementia in March 2023. This figure is predicted to surge to 13.8 million by 2060. Thus, the increase in neurological disorder cases is spurring the expansion of the neurogenomics market.

Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25845&type=smp

What Are the Segments in the Neurogenomics Market?
The neurogenomics market covered in this report is segmented -

1) By Offering: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray, Software And Services
2) By Application: Variant Discovery, Research Applications, Target Identification, Transcription Factor Binding Analysis, Functional Studies, Clinical Applications
3) By End User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Hospitals And Diagnostic Laboratories

Subsegments:
1) By Next-Generation Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing, Ribonucleic Acid Sequencing
2) By Polymerase Chain Reaction: Real-Time Polymerase Chain Reaction, Reverse Transcription Polymerase Chain Reaction, Digital Polymerase Chain Reaction
3) By Microarray: Deoxyribonucleic Acid Microarray, Ribonucleic Acid Microarray, Protein Microarray
4) By Software And Services: Data Analysis And Interpretation Software, Genomic Data Management Tools, Custom Services, Cloud-Based Platforms And Reporting Tools

What Are the Key Adoption Trends in the Neurogenomics Market?
Leading entities in the neurogenomics market are concentrating their efforts on creating innovative solutions like whole genome sequencing platforms. These are aimed at improving the diagnosis and understanding of intricate neurological conditions. These tools provide comprehensive analysis of a person's entire DNA sequence, facilitating the identification of genetic elements connected to neurological disorders. For example, in April 2023, the Germany-based firm Centogene N.V., which specializes in the diagnosis and research of rare diseases, introduced CentoGenome. This is touted as the most exhaustive whole-genome sequencing (WGS) solution for identifying rare and neurodegenerative conditions worldwide. The platform makes use of PCR-free technology for high-quality, bias-free sequencing throughout intricate genetic areas. It improves variant detection using a cutting-edge bioinformatics pipeline and expert interpretation, spotting nearly all disease-inducing variants in one test. Additionally, it offers ongoing diagnostic support throughout a patient's lifespan, with free variant reclassification and confirmatory testing as new scientific knowledge emerges.

Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25845&type=smp

Which Companies Lead the Competitive Landscape of the Neurogenomics Industry?
Major companies operating in the neurogenomics market are F. Hoffmann-La Roche Limited, Thermo Fisher Scientific Incorporated, Danaher Corporation, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Myriad Genetics Inc., GeneDx LLC, Fulgent Genetics Inc., Oxford Nanopore Technologies Plc, Vigil Neuroscience Inc., PacBio, MedGenome Labs Ltd., MGI Tech Co. Ltd., Centogene N.V., Variantyx Inc., Neurogene.

Where Are the Key Neurogenomics Market Opportunities by Region?
North America was the largest region in the neurogenomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurogenomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.